{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:00:50Z","timestamp":1790168450349,"version":"4.1.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04386-6","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:39:27Z","timestamp":1778495967000},"page":"4560-4574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long noncoding RNAs in female malignancies: critical review of molecular mechanisms, clinical gaps, and therapeutic perspectives"],"prefix":"10.1007","volume":"28","author":[{"given":"Xia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1496-6957","authenticated-orcid":false,"given":"Li","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"3","key":"4386_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4386_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","volume":"9","author":"S Chen","year":"2023","unstructured":"Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465\u201372.","journal-title":"JAMA Oncol"},{"issue":"12","key":"4386_CR3","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/s41591-022-02109-2","volume":"28","author":"F Guida","year":"2022","unstructured":"Guida F, Kidman R, Ferlay J, Sch\u00fcz J, Soerjomataram I, Kithaka B, et al. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 2022;28(12):2563\u201372.","journal-title":"Nat Med"},{"issue":"1","key":"4386_CR4","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"4386_CR5","doi-asserted-by":"publisher","first-page":"114712","DOI":"10.1016\/j.biopha.2023.114712","volume":"162","author":"T Li","year":"2023","unstructured":"Li T, Wang X, Qin S, Chen B, Yi M, Zhou J. Targeting PARP for the optimal immunotherapy efficiency in gynecologic malignancies. Biomed Pharmacother. 2023;162:114712.","journal-title":"Biomed Pharmacother"},{"key":"4386_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ctrv.2016.11.006","volume":"53","author":"A Overbeek","year":"2017","unstructured":"Overbeek A, van den Berg MH, van Leeuwen FE, Kaspers GJ, Lambalk CB, van Dulmen-den Broeder E. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review. Cancer Treat Rev. 2017;53:10\u201324.","journal-title":"Cancer Treat Rev"},{"key":"4386_CR7","doi-asserted-by":"publisher","first-page":"1225982","DOI":"10.3389\/fmed.2023.1225982","volume":"10","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Yi M. Update on diagnostic and prognostic biomarkers for women\u2019s cancers. Front Med. 2023;10:1225982.","journal-title":"Front Med"},{"issue":"4","key":"4386_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","volume":"136","author":"CP Ponting","year":"2009","unstructured":"Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629\u201341.","journal-title":"Cell"},{"issue":"4","key":"4386_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452\u201363.","journal-title":"Cancer Cell"},{"issue":"5","key":"4386_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1101\/gr.6036807","volume":"17","author":"J Ponjavic","year":"2007","unstructured":"Ponjavic J, Ponting CP, Lunter G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res. 2007;17(5):556\u201365.","journal-title":"Genome Res"},{"issue":"4","key":"4386_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2015.01.009","volume":"160","author":"DM Anderson","year":"2015","unstructured":"Anderson DM, Anderson KM, Chang CL, Makarewich CA, Nelson BR, McAnally JR, et al. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell. 2015;160(4):595\u2013606.","journal-title":"Cell"},{"issue":"26","key":"4386_CR12","doi-asserted-by":"publisher","first-page":"18648","DOI":"10.18632\/oncotarget.24307","volume":"9","author":"G Hu","year":"2018","unstructured":"Hu G, Niu F, Humburg BA, Liao K, Bendi S, Callen S, et al. Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis. Oncotarget. 2018;9(26):18648.","journal-title":"Oncotarget"},{"issue":"6113","key":"4386_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.1231776","volume":"338","author":"JT Lee","year":"2012","unstructured":"Lee JT. Epigenetic regulation by long noncoding RNAs. Science. 2012;338(6113):1435\u20139.","journal-title":"Science"},{"issue":"19","key":"4386_CR14","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1016\/j.jmb.2012.11.024","volume":"425","author":"JH Yoon","year":"2013","unstructured":"Yoon JH, Abdelmohsen K, Gorospe M. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol. 2013;425(19):3723\u201330.","journal-title":"J Mol Biol"},{"issue":"5","key":"4386_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179(5):1033\u201355.","journal-title":"Cell"},{"key":"4386_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-017-0644-5","volume":"16","author":"A Di Meo","year":"2017","unstructured":"Di Meo A, Bartlett J, Cheng Y, Pasic MD, Yousef GM. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Mol Cancer. 2017;16:1\u20134.","journal-title":"Mol Cancer"},{"issue":"5","key":"4386_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","volume":"29","author":"LE Qu","year":"2016","unstructured":"Qu LE, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29(5):653\u201368.","journal-title":"Cancer Cell"},{"issue":"23","key":"4386_CR18","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.3390\/cancers13236102","volume":"13","author":"F Naz","year":"2021","unstructured":"Naz F, Tariq I, Ali S, Somaida A, Preis E, Bakowsky U. The role of long non-coding RNAs (lncRNAs) in female oriented cancers. Cancers. 2021;13(23):6102.","journal-title":"Cancers"},{"key":"4386_CR19","doi-asserted-by":"publisher","first-page":"117618","DOI":"10.1016\/j.cca.2023.117618","volume":"551","author":"A Solati","year":"2023","unstructured":"Solati A, Thvimi S, Khatami SH, Shabaninejad Z, Malekzadegan Y, Alizadeh M, et al. Non-coding RNAs in gynecologic cancer. Clin Chim Acta. 2023;551:117618.","journal-title":"Clin Chim Acta"},{"issue":"9","key":"4386_CR20","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1101\/gr.132159.111","volume":"22","author":"T Derrien","year":"2012","unstructured":"Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775\u201389.","journal-title":"Genome Res"},{"issue":"2","key":"4386_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4386_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1348-2","volume":"18","author":"FP Marchese","year":"2017","unstructured":"Marchese FP, Raimondi I, Huarte M. The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 2017;18:1\u20133.","journal-title":"Genome Biol"},{"issue":"1","key":"4386_CR23","first-page":"3","volume":"4","author":"A Salviano-Silva","year":"2018","unstructured":"Salviano-Silva A, Lobo-Alves SC, Almeida RC, Malheiros D, Petzl-Erler ML. Besides pathology: long non-coding RNA in cell and tissue homeostasis. Noncoding RNA. 2018;4(1):3.","journal-title":"Noncoding RNA"},{"issue":"10","key":"4386_CR24","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41588-018-0207-8","volume":"50","author":"JM Kirk","year":"2018","unstructured":"Kirk JM, Kim SO, Inoue K, Smola MJ, Lee DM, Schertzer MD, et al. Functional classification of long non-coding RNAs by k-mer content. Nat Genet. 2018;50(10):1474\u201382.","journal-title":"Nat Genet"},{"issue":"3","key":"4386_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393\u2013407.","journal-title":"Cell"},{"issue":"28","key":"4386_CR26","doi-asserted-by":"publisher","first-page":"11667","DOI":"10.1073\/pnas.0904715106","volume":"106","author":"AM Khalil","year":"2009","unstructured":"Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009;106(28):11667\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4386_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gpb.2016.12.005","volume":"15","author":"IM Dykes","year":"2017","unstructured":"Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genom Proteom Bioinform. 2017;15(3):177\u201386.","journal-title":"Genom Proteom Bioinform"},{"issue":"1","key":"4386_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.gendis.2019.01.003","volume":"6","author":"RZ He","year":"2019","unstructured":"He RZ, Luo DX, Mo YY. Emerging roles of lncRNAs in the post-transcriptional regulation in cancer. Genes Dis. 2019;6(1):6\u201315.","journal-title":"Genes Dis"},{"issue":"5","key":"4386_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","volume":"21","author":"RW Yao","year":"2019","unstructured":"Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21(5):542\u201351.","journal-title":"Nat Cell Biol"},{"key":"4386_CR30","doi-asserted-by":"publisher","first-page":"146791","DOI":"10.1016\/j.gene.2022.146791","volume":"843","author":"K Cervena","year":"2022","unstructured":"Cervena K, Vodenkova S, Vymetalkova V. MALAT1 in colorectal cancer: its implication as a diagnostic, prognostic, and predictive biomarker. Gene. 2022;843:146791.","journal-title":"Gene"},{"issue":"9","key":"4386_CR31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.tibs.2016.07.003","volume":"41","author":"LL Chen","year":"2016","unstructured":"Chen LL. Linking long noncoding RNA localization and function. Trends Biochem Sci. 2016;41(9):761\u201372.","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"4386_CR32","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","volume":"1839","author":"G Yang","year":"2014","unstructured":"Yang G, Lu X, Yuan L. LncRNA a link between RNA and cancer. Biochimica et Biophysica Acta (BBA)-Gene Regulat Mech. 2014;1839(11):1097\u2013109.","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regulat Mech"},{"issue":"1","key":"4386_CR33","first-page":"17","volume":"5","author":"JC Fernandes","year":"2019","unstructured":"Fernandes JC, Acu\u00f1a SM, Aoki JI, Floeter-Winter LM, Muxel SM. Long non-coding RNAs in the regulation of gene expression: physiology and disease. Noncoding RNA. 2019;5(1):17.","journal-title":"Noncoding RNA"},{"issue":"41","key":"4386_CR34","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/onc.2017.184","volume":"36","author":"WX Peng","year":"2017","unstructured":"Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661\u20137.","journal-title":"Oncogene"},{"issue":"15","key":"4386_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/atm.2016.06.27","volume":"4","author":"N Jariwala","year":"2016","unstructured":"Jariwala N, Sarkar D. Emerging role of lncRNA in cancer: a potential avenue in molecular medicine. Ann Transl Med. 2016;4(15):1\u20135.","journal-title":"Ann Transl Med"},{"issue":"7","key":"4386_CR36","first-page":"1354","volume":"9","author":"MC Jiang","year":"2019","unstructured":"Jiang MC, Ni JJ, Cui WY, Wang BY, Zhuo W. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res. 2019;9(7):1354.","journal-title":"Am J Cancer Res"},{"key":"4386_CR37","doi-asserted-by":"publisher","first-page":"117647","DOI":"10.1016\/j.lfs.2020.117647","volume":"252","author":"KT Jin","year":"2020","unstructured":"Jin KT, Yao JY, Fang XL, Di H, Ma YY. Roles of lncRNAs in cancer: focusing on angiogenesis. Life Sci. 2020;252:117647.","journal-title":"Life Sci"},{"key":"4386_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2020.11.048","volume":"501","author":"A Nandwani","year":"2021","unstructured":"Nandwani A, Rathore S, Datta M. LncRNAs in cancer: regulatory and therapeutic implications. Cancer Lett. 2021;501:162\u201371.","journal-title":"Cancer Lett"},{"issue":"7","key":"4386_CR39","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/cas.13642","volume":"109","author":"A Sanchez Calle","year":"2018","unstructured":"Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. Emerging roles of long non\u2010coding RNA in cancer. Cancer Sci. 2018;109(7):2093\u2013100.","journal-title":"Cancer Sci"},{"issue":"1","key":"4386_CR40","doi-asserted-by":"publisher","first-page":"e3065","DOI":"10.1002\/jgm.3065","volume":"21","author":"JC de Oliveira","year":"2019","unstructured":"de Oliveira JC, Oliveira LC, Mathias C, Pedroso GA, Lemos DS, Salviano\u2010Silva A, et al. Long non\u2010coding RNAs in cancer: another layer of complexity. J Gene Med. 2019;21(1):e3065.","journal-title":"J Gene Med"},{"key":"4386_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10238-020-00638-z","volume":"20","author":"H Mu","year":"2020","unstructured":"Mu H, Zhang S, Yao Z, Liu Y, Lin K, Zhao Z, et al. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis. Clin Exp Med. 2020;20:339\u201348.","journal-title":"Clin Exp Med"},{"issue":"5","key":"4386_CR42","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/cancers12051245","volume":"12","author":"XZ Zhang","year":"2020","unstructured":"Zhang XZ, Liu H, Chen SR. Mechanisms of long non-coding RNAs in cancers and their dynamic regulations. Cancers. 2020;12(5):1245.","journal-title":"Cancers"},{"issue":"2","key":"4386_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bbrc.2018.05.157","volume":"502","author":"X Yang","year":"2018","unstructured":"Yang X, Wang L, Li R, Zhao Y, Gu Y, Liu S, et al. The long non-coding RNA PCSEAT exhibits an oncogenic property in prostate cancer and functions as a competing endogenous RNA that associates with EZH2. Biochem Biophys Res Commun. 2018;502(2):262\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"4386_CR44","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s10620-020-06581-z","volume":"66","author":"Y Cui","year":"2021","unstructured":"Cui Y, Pu R, Ye J, Huang H, Liao D, Yang Y, et al. LncRNA FAM230B promotes gastric cancer growth and metastasis by regulating the miR-27a-5p\/TOP2A axis. Dig Dis Sci. 2021;66:2637\u201350.","journal-title":"Dig Dis Sci"},{"issue":"16","key":"4386_CR45","doi-asserted-by":"publisher","first-page":"9231","DOI":"10.1111\/jcmm.15564","volume":"24","author":"G Dai","year":"2020","unstructured":"Dai G, Huang C, Yang J, Jin L, Fu K, Yuan F, et al. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR\u2010515\u20105p\/GINS2 axis. J Cell Mol Med. 2020;24(16):9231\u201343.","journal-title":"J Cell Mol Med"},{"key":"4386_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s12282-020-01048-5","volume":"27","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li Z, Chen M, Chen H, Zhong Q, Liang L, et al. LncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer. Breast Cancer Tokyo Japan. 2020;27:573\u201385.","journal-title":"Breast Cancer Tokyo Japan"},{"key":"4386_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-01816-z","volume":"21","author":"L Qi","year":"2021","unstructured":"Qi L, Sun B, Yang B, Lu S. CircMMP11 regulates proliferation, migration, invasion, and apoptosis of breast cancer cells through miR-625-5p\/ZEB2 axis. Cancer Cell Int. 2021;21:1\u20132.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4386_CR48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-022-01567-z","volume":"21","author":"R Yang","year":"2022","unstructured":"Yang R, Chen H, Xing L, Wang B, Hu M, Ou X, et al. Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10. Mol Cancer. 2022;21(1):88.","journal-title":"Mol Cancer"},{"key":"4386_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01476-7","volume":"21","author":"Y Ling","year":"2022","unstructured":"Ling Y, Liang G, Lin Q, Fang X, Luo Q, Cen Y, et al. CircCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer. Mol Cancer. 2022;21:1\u20136.","journal-title":"Mol Cancer"},{"issue":"4","key":"4386_CR50","doi-asserted-by":"crossref","first-page":"490","DOI":"10.21147\/j.issn.1000-9604.2021.04.06","volume":"33","author":"J Tang","year":"2021","unstructured":"Tang J, Yu L, Zhang W, Li X, Wang J. Advances in the treatment of metastatic breast cancer. Chin J Cancer Res. 2021;33(4):490\u2013502.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"4386_CR51","first-page":"101","volume":"27","author":"V Prasad","year":"2022","unstructured":"Prasad V, Toi M, Iwata H, Mukai H, Ito Y, Morita S, et al. A comprehensive review of current and future treatment strategies for breast cancer. Int J Clin Oncol. 2022;27(1):101\u201315.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"4386_CR52","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/1878-0261.12866","volume":"15","author":"D Zhou","year":"2021","unstructured":"Zhou D, Ren K, Wang M, Wang J, Li E, Hou C, et al. Long non\u2010coding RNA RACGAP1P promotes breast cancer invasion and metastasis via miR\u2010345\u20105p\/RACGAP1\u2010mediated mitochondrial fission. Mol Oncol. 2021;15(2):543\u201359.","journal-title":"Mol Oncol"},{"issue":"1","key":"4386_CR53","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/cam4.2675","volume":"9","author":"G Bao","year":"2020","unstructured":"Bao G, Huang J, Pan W, Li X, Zhou T. Long noncoding RNA CERS6\u2010AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA. Cancer Med. 2020;9(1):278\u201389.","journal-title":"Cancer Med"},{"key":"4386_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01210-9","volume":"19","author":"X Jin","year":"2020","unstructured":"Jin X, Ge LP, Li DQ, Shao ZM, Di GH, Xu XE, et al. LncRNA TROJAN promotes proliferation and resistance to CDK4\/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer. Mol Cancer. 2020;19:1\u20138.","journal-title":"Mol Cancer"},{"issue":"2","key":"4386_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/CBM-190721","volume":"29","author":"X Liu","year":"2020","unstructured":"Liu X, Yao W, Xiong H, Li Q, Li Y. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p\/CCND1 axis. Cancer Biomark. 2020;29(2):277\u201390.","journal-title":"Cancer Biomark"},{"key":"4386_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01410-9","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y, Gong G, Xu J, Zhang Y, Wu S, Wang S. Long noncoding RNA HOTAIR promotes breast cancer development by targeting ZEB1 via sponging miR-601. Cancer Cell Int. 2020;20:1\u20133.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"4386_CR57","first-page":"497","volume":"45","author":"Y Liu","year":"2020","unstructured":"Liu Y, Li M, Yu H, Piao H. lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR\u2011125a\u20115p. Int J Mol Med. 2020;45(2):497\u2013509.","journal-title":"Int J Mol Med"},{"key":"4386_CR58","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.biopha.2018.05.056","volume":"104","author":"S Li","year":"2018","unstructured":"Li S, Zhou J, Wang Z, Wang P, Gao X, Wang Y. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Biomed Pharmacother. 2018;104:451\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4386_CR59","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1038\/s41467-020-19349-w","volume":"11","author":"Q Shi","year":"2020","unstructured":"Shi Q, Li Y, Li S, Jin L, Lai H, Wu Y, et al. LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer. Nat Commun. 2020;11(1):5513.","journal-title":"Nat Commun"},{"key":"4386_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-019-0747-0","volume":"12","author":"J Wang","year":"2019","unstructured":"Wang J, Xie S, Yang J, Xiong H, Jia Y, Zhou Y, et al. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy. J Hematol Oncol. 2019;12:1\u20134.","journal-title":"J Hematol Oncol"},{"key":"4386_CR61","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8124570","author":"G Dong","year":"2020","unstructured":"Dong G, Wang X, Jia Y, Jia Y, Zhao W, Zhang J, et al. HAND2-AS1 works as a ceRNA of miR-3118 to suppress proliferation and migration in breast cancer by upregulating PHLPP2. BioMed Res Int. 2020. https:\/\/doi.org\/10.1155\/2020\/8124570.","journal-title":"BioMed Res Int"},{"issue":"1","key":"4386_CR62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/CBM-190530","volume":"27","author":"Y Wang","year":"2020","unstructured":"Wang Y, Cai X. Long noncoding RNA HAND2-AS1 restrains proliferation and metastasis of breast cancer cells through sponging miR-1275 and promoting SOX7. Cancer Biomark. 2020;27(1):85\u201394.","journal-title":"Cancer Biomark"},{"key":"4386_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-021-01844-7","volume":"40","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang Y, Jiang L, Song X, Zheng A, Gao H, et al. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1\/MEK4-mediated MAPK signal pathway. J Exp Clin Cancer Res. 2021;40:1\u20134.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"4386_CR64","doi-asserted-by":"publisher","first-page":"8893","DOI":"10.18632\/aging.103012","volume":"12","author":"R Zheng","year":"2020","unstructured":"Zheng R, Jia J, Guan L, Yuan H, Liu K, Liu C, et al. Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-\u03baB\/GATA3 axis in breast cancer. Aging (Albany NY). 2020;12(10):8893.","journal-title":"Aging (Albany NY)"},{"key":"4386_CR65","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.omtn.2020.01.030","volume":"19","author":"Z Chen","year":"2020","unstructured":"Chen Z, Pan T, Jiang D, Jin L, Geng Y, Feng X, et al. The lncRNA-GAS5\/miR-221-3p\/DKK2 axis modulates ABCB1-mediated adriamycin resistance of breast cancer via the Wnt\/\u03b2-catenin signaling pathway. Mol Ther Nucl Acids. 2020;19:1434\u201348.","journal-title":"Mol Ther Nucl Acids"},{"key":"4386_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02682-5","volume":"19","author":"A Hu","year":"2021","unstructured":"Hu A, Hong F, Li D, Jin Y, Kon L, Xu Z, et al. Long non-coding RNA ROR recruits histone transmethylase MLL1 to up-regulate TIMP3 expression and promote breast cancer progression. J Transl Med. 2021;19:1\u20133.","journal-title":"J Transl Med"},{"key":"4386_CR67","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S243482","author":"H Feng","year":"2020","unstructured":"Feng H, Wang Q, Xiao W, Zhang B, Jin Y, Lu H. LncRNA TTN-AS1 regulates miR-524-5p and RRM2 to promote breast cancer progression. OncoTargets Ther. 2020. https:\/\/doi.org\/10.2147\/OTT.S243482.","journal-title":"OncoTargets Ther"},{"issue":"10","key":"4386_CR68","doi-asserted-by":"publisher","first-page":"592757","DOI":"10.3389\/fonc.2020.592757","volume":"24","author":"ZH Li","year":"2020","unstructured":"Li ZH, Yu NS, Deng Q, Zhang Y, Hu YY, Liu G, et al. LncRNA SNHG7 mediates the chemoresistance and stemness of breast cancer by sponging miR-34a. Front Oncol. 2020;24(10):592757.","journal-title":"Front Oncol"},{"key":"4386_CR69","doi-asserted-by":"publisher","first-page":"108869","DOI":"10.1016\/j.biopha.2019.108869","volume":"115","author":"J Wu","year":"2019","unstructured":"Wu J, Chen H, Ye M, Wang B, Zhang Y, Sheng J, et al. Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression. Biomed Pharmacother. 2019;115:108869.","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"4386_CR70","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.3390\/cancers17193191","volume":"17","author":"SH Lye","year":"2025","unstructured":"Lye SH, Polycarp N, Durojaye TJ, Tollefsbol TO. Functional heterogeneity and context-dependent roles of LncRNAs in breast cancer. Cancers. 2025;17(19):3191.","journal-title":"Cancers"},{"issue":"10","key":"4386_CR71","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/biology10100987","volume":"10","author":"HR Pinkney","year":"2021","unstructured":"Pinkney HR, Black MA, Diermeier SD. Single-cell expression profiling reveals heterogeneous lncRNA expression in triple-negative breast cancer xenografts. Biology. 2021;10(10):987.","journal-title":"Biology"},{"issue":"2","key":"4386_CR72","doi-asserted-by":"publisher","first-page":"e70119","DOI":"10.1111\/cpr.70119","volume":"59","author":"X Zhao","year":"2025","unstructured":"Zhao X, Qiu Y, Chen J, Wang D, Wang Z, Ma S, et al. Non-coding RNAs in breast cancer radioresistance: mechanisms, functional roles and translational potentials. Cellular Proliferat. 2025;59(2):e70119.","journal-title":"Cellular Proliferat"},{"issue":"2","key":"4386_CR73","doi-asserted-by":"publisher","first-page":"114365","DOI":"10.1016\/j.yexcr.2024.114365","volume":"444","author":"TM Al-Noshokaty","year":"2024","unstructured":"Al-Noshokaty TM, El-Sayyad GS, Abdelhamid R, Mansour A, Abdellatif N, Alaaeldien A, et al. Long non-coding RNAs and their role in breast cancer pathogenesis and drug resistance: Navigating the non-coding landscape review. Exp Cell Res. 2024;444(2):114365.","journal-title":"Exp Cell Res"},{"key":"4386_CR74","doi-asserted-by":"publisher","first-page":"104102","DOI":"10.1016\/j.critrevonc.2023.104102","volume":"190","author":"Y Lei","year":"2023","unstructured":"Lei Y, He J, Tang Y. Long non-coding RNA and the tumor microenvironment: prospects for clinical applications in breast cancer. Crit Rev Oncol\/Hematol. 2023;190:104102.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"2","key":"4386_CR75","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.3802\/jgo.2022.33.e15","volume":"33","author":"JR Smith","year":"2022","unstructured":"Smith JR, et al. The lncRNA landscape of ovarian cancer subtypes. J Gynecol Oncol. 2022;33(2):e15.","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"4386_CR76","first-page":"789","volume":"83","author":"L Chen","year":"2023","unstructured":"Chen L, Wang H. Unraveling the role of long non-coding RNAs in rare ovarian cancers. Cancer Res. 2023;83(5):789\u2013801.","journal-title":"Cancer Res"},{"issue":"3","key":"4386_CR77","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4143\/crt.2016.263","volume":"49","author":"GW Yim","year":"2017","unstructured":"Yim GW, Kim HJ, Kim LK, Kim SW, Kim S, Nam EJ, et al. Long non-coding RNA HOXA11 antisense promotes cell proliferation and invasion and predicts patient prognosis in serous ovarian cancer. Cancer Res Treat. 2017;49(3):656.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"4386_CR78","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41598-017-00763-y","volume":"7","author":"K Yang","year":"2017","unstructured":"Yang K, Hou Y, Li A, Li Z, Wang W, Xie H, et al. Identification of a six-lncRNA signature associated with recurrence of ovarian cancer. Sci Rep. 2017;7(1):752.","journal-title":"Sci Rep"},{"issue":"9","key":"4386_CR79","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1158\/1078-0432.CCR-16-1402","volume":"23","author":"P Martini","year":"2017","unstructured":"Martini P, Paracchini L, Caratti G, Mello-Grand M, Fruscio R, Beltrame L, et al. lncRNAs as novel indicators of patients\u2019 prognosis in stage I epithelial ovarian cancer: a retrospective and multicentric study. Clin Cancer Res. 2017;23(9):2356\u201366.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4386_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2014.03.556","volume":"134","author":"JJ Qiu","year":"2014","unstructured":"Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW, Jin HY, et al. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol Oncol. 2014;134(1):121\u20138.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"4386_CR81","first-page":"20565","volume":"8","author":"E Liu","year":"2015","unstructured":"Liu E, Liu Z, Zhou Y, Mi R, Wang D. Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways. Int J Clin Exp Med. 2015;8(11):20565.","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"4386_CR82","first-page":"3803","volume":"8","author":"E Liu","year":"2015","unstructured":"Liu E, Liu Z, Zhou Y. Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1. Int J Clin Exp Pathol. 2015;8(4):3803.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"4386_CR83","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3892\/or.2014.3208","volume":"32","author":"X Sheng","year":"2014","unstructured":"Sheng X, Li J, Yang L, Chen Z, Zhao Q, Tan L, et al. Promoter hypermethylation influences the suppressive role of Maternally Expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Oncol Rep. 2014;32(1):277\u201385.","journal-title":"Oncol Rep"},{"issue":"10","key":"4386_CR84","first-page":"769","volume":"1","author":"KC Huang","year":"2002","unstructured":"Huang KC, Rao PH, Lau CC, Heard E, Ng SK, Brown C, et al. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002;1(10):769\u201376.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"4386_CR85","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ygyno.2014.02.033","volume":"133","author":"X Zhou","year":"2014","unstructured":"Zhou X, Gao Q, Wang J, Zhang X, Liu K, Duan Z. Linc-RNA-RoR acts as a \u201csponge\u201d against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. Gynecol Oncol. 2014;133(2):333\u20139.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"4386_CR86","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3892\/ijo.2015.2897","volume":"46","author":"W Zhai","year":"2015","unstructured":"Zhai W, Li X, Wu S, Zhang Y, Pang H, Chen W. Microarray expression profile of lncRNAs and the upregulated ASLNC04080 lncRNA in human endometrial carcinoma. Int J Oncol. 2015;46(5):2125\u201337.","journal-title":"Int J Oncol"},{"issue":"18","key":"4386_CR87","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1158\/0008-5472.CAN-14-0427","volume":"74","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Yang Y, Trovik J, Sun K, Zhou L, Jiang P, et al. A novel Wnt regulatory axis in endometrioid endometrial cancer. Cancer Res. 2014;74(18):5103\u201317.","journal-title":"Cancer Res"},{"issue":"3","key":"4386_CR88","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/ijgc-00009577-200405000-00015","volume":"14","author":"V Tanos","year":"2004","unstructured":"Tanos V, Ariel I, Prus D, De-Groot N, Hochberg A. H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium. Int J Gynecol Cancer. 2004;14(3):521\u20135.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"4386_CR89","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/IGC.0000000000000121","volume":"24","author":"J Huang","year":"2014","unstructured":"Huang J, Ke P, Guo L, Wang W, Tan H, Liang Y, et al. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo. Int J Gynecol Cancer. 2014;24(4):635\u201342.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"4386_CR90","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3892\/ijmm.2013.1570","volume":"33","author":"X He","year":"2014","unstructured":"He X, Bao W, Li X, Chen Z, Che Q, Wang H, et al. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis. Int J Mol Med. 2014;33(2):325\u201332.","journal-title":"Int J Mol Med"},{"key":"4386_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-015-0213-4","volume":"22","author":"C Guo","year":"2015","unstructured":"Guo C, Song WQ, Sun P, Jin L, Dai HY. LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells. J Biomed Sci. 2015;22:1\u20139.","journal-title":"J Biomed Sci"},{"issue":"11","key":"4386_CR92","doi-asserted-by":"publisher","first-page":"e80306","DOI":"10.1371\/journal.pone.0080306","volume":"8","author":"R Akrami","year":"2013","unstructured":"Akrami R, Jacobsen A, Hoell J, Schultz N, Sander C, Larsson E. Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification. PLoS ONE. 2013;8(11):e80306.","journal-title":"PLoS ONE"},{"issue":"12","key":"4386_CR93","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.3390\/ijms22126506","volume":"22","author":"R Di Fiore","year":"2021","unstructured":"Di Fiore R, Suleiman S, Felix A, O\u2019Toole SA, O\u2019Leary JJ, Ward MP, et al. An overview of the role of long non-coding RNAs in human choriocarcinoma. Int J Mol Sci. 2021;22(12):6506.","journal-title":"Int J Mol Sci"},{"key":"4386_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2121-14-26","volume":"14","author":"LL Yu","year":"2013","unstructured":"Yu LL, Chang K, Lu LS, Zhao D, Han J, Zheng YR, et al. Lentivirus-mediated RNA interference targeting the H19 gene inhibits cell proliferation and apoptosis in human choriocarcinoma cell line JAR. BMC Cell Biol. 2013;14:1\u20139.","journal-title":"BMC Cell Biol"},{"issue":"9","key":"4386_CR95","doi-asserted-by":"publisher","first-page":"15131","DOI":"10.1002\/jcb.28775","volume":"120","author":"S Yu","year":"2019","unstructured":"Yu S, Wu C, Tan Q, Liu H. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells. J Cell Biochem. 2019;120(9):15131\u201344.","journal-title":"J Cell Biochem"},{"issue":"4","key":"4386_CR96","doi-asserted-by":"publisher","first-page":"e22455","DOI":"10.1002\/jbt.22455","volume":"34","author":"L Ji","year":"2020","unstructured":"Ji L, Ma L. MEG3 is restored by schisandrin A and represses tumor growth in choriocarcinoma cells. J Biochem Mol Toxicol. 2020;34(4):e22455.","journal-title":"J Biochem Mol Toxicol"},{"key":"4386_CR97","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.biopha.2017.10.083","volume":"97","author":"D Shi","year":"2018","unstructured":"Shi D, Zhang Y, Lu R, Zhang Y. The long non-coding RNA MALAT1 interacted with miR-218 modulates choriocarcinoma growth by targeting Fbxw8. Biomed Pharmacother. 2018;97:543\u201350.","journal-title":"Biomed Pharmacother"},{"key":"4386_CR98","first-page":"990","volume":"46","author":"X Zhao","year":"2017","unstructured":"Zhao X, Cheng R, Ouyang L. Effects of long non-coding RNA HOTAIR on the biological behaviors of vulvar squamous cell carcinoma A431 cells. J China Med Univ. 2017;46:990\u20134.","journal-title":"J China Med Univ"},{"issue":"1","key":"4386_CR99","first-page":"250","volume":"160","author":"KL Jones","year":"2021","unstructured":"Jones KL, et al. Molecular subtypes of cervical cancer: a review of current classifications and emerging biomarkers. Gynecol Oncol. 2021;160(1):250\u20138.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4386_CR100","first-page":"315","volume":"32","author":"S Lee","year":"2022","unstructured":"Lee S, Kim Y. Long non-coding RNAs in the progression of cervical squamous cell carcinoma. Int J Gynecol Cancer. 2022;32(3):315\u201323.","journal-title":"Int J Gynecol Cancer"},{"key":"4386_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-018-0567-2","volume":"18","author":"X Wang","year":"2018","unstructured":"Wang X, Wang G, Zhang L, Cong J, Hou J, Liu C. LncRNA PVT1 promotes the growth of HPV positive and negative cervical squamous cell carcinoma by inhibiting TGF-\u03b21. Cancer Cell Int. 2018;18:1\u20138.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"4386_CR102","doi-asserted-by":"publisher","first-page":"672","DOI":"10.7150\/jca.28525","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang X, Mao L, Li L, He Z, Wang N, Song Y. Long noncoding RNA GIHCG functions as an oncogene and serves as a serum diagnostic biomarker for cervical cancer. J Cancer. 2019;10(3):672.","journal-title":"J Cancer"},{"issue":"2","key":"4386_CR103","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/jcp.29015","volume":"235","author":"W Luo","year":"2020","unstructured":"Luo W, Wang M, Liu J, Cui X, Wang H. Identification of a six lncRNAs signature as novel diagnostic biomarkers for cervical cancer. J Cell Physiol. 2020;235(2):993\u20131000.","journal-title":"J Cell Physiol"},{"issue":"1","key":"4386_CR104","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1038\/s41598-017-06502-7","volume":"7","author":"J Zhang","year":"2017","unstructured":"Zhang J, Yao T, Lin Z, Gao Y. Aberrant methylation of MEG3 functions as a potential plasma-based biomarker for cervical cancer. Sci Rep. 2017;7(1):6271.","journal-title":"Sci Rep"},{"issue":"4","key":"4386_CR105","first-page":"2431","volume":"41","author":"H Bo","year":"2019","unstructured":"Bo H, Fan L, Gong Z, Liu Z, Shi L, Guo C, et al. Upregulation and hypomethylation of lncRNA AFAP1\u2011AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer. Oncol Rep. 2019;41(4):2431\u20139.","journal-title":"Oncol Rep"},{"key":"4386_CR106","doi-asserted-by":"publisher","first-page":"197907","DOI":"10.1016\/j.virusres.2020.197907","volume":"281","author":"Y Hao","year":"2020","unstructured":"Hao Y, Yan Z, Zhang A, Hu S, Wang N, Luo XG, et al. IL-6\/STAT3 mediates the HPV18 E6\/E7 stimulated upregulation of MALAT1 gene in cervical cancer HeLa cells. Virus Res. 2020;281:197907.","journal-title":"Virus Res"},{"key":"4386_CR107","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.biopha.2018.05.053","volume":"105","author":"H Zhu","year":"2018","unstructured":"Zhu H, Zheng T, Yu J, Zhou L, Wang L. LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a. Biomed Pharmacother. 2018;105:789\u201397.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"4386_CR108","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1002\/jcp.27403","volume":"234","author":"XJ Jin","year":"2019","unstructured":"Jin XJ, Chen XJ, Zhang ZF, Hu WS, Ou RY, Li S, et al. Long noncoding RNA SNHG12 promotes the progression of cervical cancer via modulating miR\u2010125b\/STAT3 axis. J Cell Physiol. 2019;234(5):6624\u201332.","journal-title":"J Cell Physiol"},{"key":"4386_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2017.11.003","volume":"637","author":"H Zhu","year":"2018","unstructured":"Zhu H, Zeng Y, Zhou CC, Ye W. SNHG16\/miR-216-5p\/ZEB1 signal pathway contributes to the tumorigenesis of cervical cancer cells. Arch Biochem Biophys. 2018;637:1\u20138.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"4386_CR110","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/jcb.29181","volume":"121","author":"J Xu","year":"2020","unstructured":"Xu J, Zhang J. LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p\/ARF1 axis. J Cell Biochem. 2020;121(1):344\u201352.","journal-title":"J Cell Biochem"},{"issue":"4","key":"4386_CR111","first-page":"3371","volume":"20","author":"H Zhang","year":"2019","unstructured":"Zhang H, Xue B, Wang S, Li X, Fan T. Long non\u2011coding RNA TP73 antisense RNA 1 facilitates the proliferation and migration of cervical cancer cells via regulating microRNA\u2011607\/cyclin D2. Mol Med Rep. 2019;20(4):3371\u20138.","journal-title":"Mol Med Rep"},{"issue":"13","key":"4386_CR112","first-page":"5611","volume":"23","author":"CN Liu","year":"2019","unstructured":"Liu CN, Zhang HY, Liu CL, Wang CC. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt\/\u03b2-catenin pathway. Eur Rev Med Pharmacol Sci. 2019;23(13):5611\u201320.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4386_CR113","doi-asserted-by":"publisher","first-page":"108726","DOI":"10.1016\/j.biopha.2019.108726","volume":"117","author":"JJ Zhang","year":"2019","unstructured":"Zhang JJ, Fan LP. Long non-coding RNA CRNDE enhances cervical cancer progression by suppressing PUMA expression. Biomed Pharmacother. 2019;117:108726.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4386_CR114","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41419-017-0249-3","volume":"9","author":"H Li","year":"2018","unstructured":"Li H, Jia Y, Cheng J, Liu G, Song F. LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1\/miR-6857\/CDK1 pathway. Cell Death Dis. 2018;9(2):198.","journal-title":"Cell Death Dis"},{"issue":"3","key":"4386_CR115","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3727\/096504017X15017209042610","volume":"26","author":"L Ou","year":"2018","unstructured":"Ou L, Wang D, Zhang H, Yu Q, Hua F. Decreased expression of miR-138-5p by lncRNA H19 in cervical cancer promotes tumor proliferation. Oncol Res. 2018;26(3):401\u201310.","journal-title":"Oncol Res"},{"key":"4386_CR116","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12935-019-0893-z","volume":"19","author":"J Zhang","year":"2019","unstructured":"Zhang J, Gao Y. Long non-coding RNA MEG3 inhibits cervical cancer cell growth by promoting degradation of P-STAT3 protein via ubiquitination. Cancer Cell Int. 2019;19:175.","journal-title":"Cancer Cell Int"},{"issue":"12","key":"4386_CR117","doi-asserted-by":"publisher","first-page":"23571","DOI":"10.1002\/jcp.28926","volume":"234","author":"W Yang","year":"2019","unstructured":"Yang W, Xu X, Hong L, Wang Q, Huang J, Jiang L. Upregulation of lncRNA GAS5 inhibits the growth and metastasis of cervical cancer cells. J Cell Physiol. 2019;234(12):23571\u201380.","journal-title":"J Cell Physiol"},{"issue":"7","key":"4386_CR118","doi-asserted-by":"publisher","first-page":"101042831771131","DOI":"10.1177\/1010428317711315","volume":"39","author":"W Yang","year":"2017","unstructured":"Yang W, Hong L, Xu X, Wang Q, Huang J, Jiang L. LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205. Tumor Biol. 2017;39(7):1010428317711315.","journal-title":"Tumor Biol"},{"issue":"6","key":"4386_CR119","doi-asserted-by":"publisher","first-page":"9605","DOI":"10.1002\/jcp.27647","volume":"234","author":"T Yao","year":"2019","unstructured":"Yao T, Lu R, Zhang J, Fang X, Fan L, Huang C, et al. Growth arrest\u2010specific 5 attenuates cisplatin\u2010induced apoptosis in cervical cancer by regulating STAT3 signaling via miR\u201021. J Cell Physiol. 2019;234(6):9605\u201315.","journal-title":"J Cell Physiol"},{"issue":"10","key":"4386_CR120","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.1002\/jcp.29529","volume":"235","author":"Y Shi","year":"2020","unstructured":"Shi Y, Liu M, Huang Y, Zhang J, Yin L. Promotion of cell autophagy and apoptosis in cervical cancer by inhibition of long noncoding RNA LINC00511 via transcription factor RXRA\u2010regulated PLD1. J Cell Physiol. 2020;235(10):6592\u2013604.","journal-title":"J Cell Physiol"},{"issue":"4","key":"4386_CR121","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jog.15177","volume":"48","author":"L Jiang","year":"2022","unstructured":"Jiang L, Li X, Zhang Y, Liu J, Wang H, Chen S, et al. LncRNA KCNQ1OT1-mediated cervical cancer progression by sponging miR-1270 as a ceRNA of LOXL2 through PI3k\/Akt pathway. J Obstet Gynaecol Res. 2022;48(4):1023\u201334.","journal-title":"J Obstet Gynaecol Res"},{"key":"4386_CR122","doi-asserted-by":"crossref","first-page":"104589","DOI":"10.1016\/j.critrevonc.2024.104589","volume":"206","author":"V Teixeira","year":"2025","unstructured":"Teixeira V, Oliveira D, Santos L, Martins T, Silva A, Ferreira M, et al. Non-coding RNAs and liquid biopsies: emerging biomarkers for cervical cancer. Crit Rev Oncol Hematol. 2025;206:104589.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"34","key":"4386_CR123","doi-asserted-by":"crossref","first-page":"54867","DOI":"10.18632\/oncotarget.10253","volume":"7","author":"C Liu","year":"2016","unstructured":"Liu C, Zhao L, Luo Y, Li M, Wang X, Zhang Y, et al. Comprehensive analysis of lncRNAs microarray profile and mRNA-lncRNA co-expression in oncogenic HPV-positive cervical cancer cell lines. Oncotarget. 2016;7(34):54867\u201378.","journal-title":"Oncotarget"},{"issue":"1","key":"4386_CR124","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41420-025-02861-7","volume":"11","author":"L Guo","year":"2025","unstructured":"Guo L, Hua K. Unraveling the mechanisms of LncRNAs in cervical cancer: a comprehensive review. Cell Death Discov. 2025;11(1):12.","journal-title":"Cell Death Discov"},{"issue":"41","key":"4386_CR125","doi-asserted-by":"publisher","first-page":"e39957","DOI":"10.1097\/MD.0000000000039957","volume":"103","author":"N Shao","year":"2024","unstructured":"Shao N. Research progress on human papillomavirus-negative cervical cancer: a review. Medicine (Baltimore). 2024;103(41):e39957.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"4386_CR126","first-page":"1095","volume":"49","author":"Z Liu","year":"2024","unstructured":"Liu Z, Luo L, Wu X, Wang B, Wang M, Li X. Identification of apoptosis-related long non-coding RNA expression profiles in patients with cervical intraepithelial neoplasia grade 3. J Centr South Univ (Med Sci). 2024;49(7):1095\u2013108.","journal-title":"J Centr South Univ (Med Sci)"},{"issue":"3","key":"4386_CR127","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/ijgc-00009577-200405000-00015","volume":"14","author":"V Tanos","year":"2004","unstructured":"Tanos V, Ariel I, Prus D, De-Groot N, Hochberg A. H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium. Int J Gynecol Cancer. 2004;14(3):521\u20135.","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"4386_CR128","doi-asserted-by":"publisher","first-page":"11219","DOI":"10.1002\/jcp.27772","volume":"234","author":"F Shen","year":"2019","unstructured":"Shen F, Zheng H, Zhou L, Li W, Xu X. Overexpression of MALAT1 contributes to cervical cancer progression by acting as a sponge of miR-429. J Cell Physiol. 2019;234(7):11219\u201326.","journal-title":"J Cell Physiol"},{"issue":"1","key":"4386_CR129","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/jog.14418","volume":"47","author":"Q Gao","year":"2021","unstructured":"Gao Q, Fang X, Chen Y, Li Z, Wang M. Exosomal lncRNA UCA1 from cancer-associated fibroblasts enhances chemoresistance in vulvar squamous cell carcinoma cells. J Obstetr Gynaecol Res. 2021;47(1):73\u201387.","journal-title":"J Obstetr Gynaecol Res"},{"issue":"4","key":"4386_CR130","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.21037\/tcr.2019.08.11","volume":"8","author":"H Wang","year":"2019","unstructured":"Wang H, Ouyang L, Gao S. Effects of antisense lncRNA PCBP1-AS1 on biological behaviors of vulvar squamous carcinoma cells by regulating TRAF5 and NF-\u03baB expression. Transl Cancer Res. 2019;8(4):1578.","journal-title":"Transl Cancer Res"},{"issue":"38","key":"4386_CR131","doi-asserted-by":"publisher","first-page":"41045","DOI":"10.18632\/oncotarget.5728","volume":"6","author":"D Wang","year":"2015","unstructured":"Wang D, Ding L, Wang L, Zhao Y, Sun Z, Karnes RJ, et al. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer. Oncotarget. 2015;6(38):41045.","journal-title":"Oncotarget"},{"issue":"34","key":"4386_CR132","doi-asserted-by":"publisher","first-page":"17861","DOI":"10.1074\/jbc.M116.718536","volume":"291","author":"A Misawa","year":"2016","unstructured":"Misawa A, Takayama KI, Urano T, Inoue S. Androgen-induced long noncoding RNA (lncRNA) SOCS2-AS1 promotes cell growth and inhibits apoptosis in prostate cancer cells. J Biol Chem. 2016;291(34):17861\u201380.","journal-title":"J Biol Chem"},{"issue":"8","key":"4386_CR133","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.biocel.2013.05.030","volume":"45","author":"CH Li","year":"2013","unstructured":"Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol. 2013;45(8):1895\u2013910.","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"4386_CR134","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1111\/jcmm.13604","volume":"22","author":"D Xue","year":"2018","unstructured":"Xue D, Lu H, Xu HY, Zhou CX, He XZ. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12. J Cell Mol Med. 2018;22(6):3223\u201337.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4386_CR135","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gad.270959.115","volume":"30","author":"G Arun","year":"2016","unstructured":"Arun G, Diermeier S, Akerman M, Chang KC, Wilkinson JE, Hearn S, et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev. 2016;30(1):34\u201351.","journal-title":"Genes Dev"},{"issue":"3","key":"4386_CR136","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","volume":"73","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Ei\u00dfmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73(3):1180\u20139.","journal-title":"Cancer Res"},{"issue":"7","key":"4386_CR137","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnci\/dju113","volume":"106","author":"PY Liu","year":"2014","unstructured":"Liu PY, Erriquez D, Marshall GM, Tee AE, Polly P, Wong M, et al. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. J Nat Cancer Inst. 2014;106(7):113.","journal-title":"J Nat Cancer Inst"},{"issue":"9","key":"4386_CR138","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1177\/1087057115594187","volume":"20","author":"R Pedram Fatemi","year":"2015","unstructured":"Pedram Fatemi R, Salah-Uddin S, Modarresi F, Khoury N, Wahlestedt C, Faghihi MA. Screening for small-molecule modulators of long noncoding RNA-protein interactions using AlphaScreen. J Biomol Screen. 2015;20(9):1132\u201341.","journal-title":"J Biomol Screen"},{"issue":"2","key":"4386_CR139","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1021\/acschembio.8b00807","volume":"14","author":"FA Abulwerdi","year":"2019","unstructured":"Abulwerdi FA, Xu W, Ageeli AA, Yonkunas MJ, Arun G, Nam H, et al. Selective small-molecule targeting of a triple helix encoded by the long noncoding RNA, MALAT1. ACS Chem Biol. 2019;14(2):223\u201335.","journal-title":"ACS Chem Biol"},{"key":"4386_CR140","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.canlet.2019.10.026","volume":"469","author":"N Mercatelli","year":"2020","unstructured":"Mercatelli N, Fortini D, Palombo R, Paronetto MP. Small molecule inhibition of Ewing sarcoma cell growth via targeting the long non coding RNA HULC. Cancer Lett. 2020;469:111\u201323.","journal-title":"Cancer Lett"},{"issue":"1","key":"4386_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-019-0748-z","volume":"12","author":"WT Wang","year":"2019","unstructured":"Wang WT, Han C, Sun YM, Chen TQ, Chen YQ. Noncoding RNAs in cancer therapy resistance and targeted drug development. J Hematol Oncol. 2019;12(1):1\u20135.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"4386_CR142","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.eururo.2019.07.040","volume":"76","author":"VR Ramnarine","year":"2019","unstructured":"Ramnarine VR, Kobelev M, Gibb EA, Nouri M, Lin D, Wang Y, et al. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management. Eur Urol. 2019;76(5):546\u201359.","journal-title":"Eur Urol"},{"key":"4386_CR143","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-025-04020-x","author":"S Elkholey","year":"2025","unstructured":"Elkholey S, et al. LncRNAs signatures in gynecological cancers: ovarian and endometrial cancers. Clin Transl Oncol. 2025. https:\/\/doi.org\/10.1007\/s12094-025-04020-x.","journal-title":"Clin Transl Oncol"},{"key":"4386_CR144","doi-asserted-by":"publisher","first-page":"105091","DOI":"10.1016\/j.critrevonc.2025.105091","volume":"218","author":"M Teixeira Costa","year":"2025","unstructured":"Teixeira Costa M, Oliveira D, Santos L, Martins T, Silva A, Ferreira M, et al. Non-coding RNAs and liquid biopsies: emerging biomarkers for cervical cancer. Crit Rev Oncol Hematol. 2025;218:105091.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"4386_CR145","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/ijmm.2024.5411","volume":"54","author":"X Wang","year":"2024","unstructured":"Wang X, et al. Role of exosomal non-coding RNAs in ovarian cancer (Review). Int J Mol Med. 2024;54(4):87.","journal-title":"Int J Mol Med"},{"key":"4386_CR146","doi-asserted-by":"publisher","first-page":"149217","DOI":"10.1016\/j.gene.2025.149217","volume":"941","author":"CY Hsu","year":"2025","unstructured":"Hsu CY, et al. From diagnosis to therapy: the role of LncRNA GAS5 in combatting some cancers affecting women. Gene. 2025;941:149217.","journal-title":"Gene"},{"issue":"178","key":"4386_CR147","doi-asserted-by":"publisher","first-page":"877","DOI":"10.24976\/Discov.Med.202335178.83","volume":"35","author":"F Zhou","year":"2023","unstructured":"Zhou F, et al. Regulations of exosomal-transmitted AFAP1-AS1 LncRNA on ovarian cancer cell migration and invasion. Discov Med. 2023;35(178):877\u201386.","journal-title":"Discov Med"},{"issue":"1","key":"4386_CR148","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12672-025-01848-1","volume":"16","author":"N Afroze","year":"2025","unstructured":"Afroze N, Sundaram MK, Haque S, Hussain A. Long non-coding RNA involved in the carcinogenesis of human female cancer\u2014a comprehensive review. Discov Oncol. 2025;16(1):122.","journal-title":"Discov Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04386-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04386-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04386-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:03:20Z","timestamp":1790165000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04386-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":148,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4386"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04386-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to report.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}